Digitisation | January 14, 2022
Hekka Labs introduces decentralized chronic disease data management in South Asia
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Both companies will combine their expertise to channel real-world evidence toward ground-breaking new treatments in rare diseases
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
Barbara Engelhardt moves her computational and statistics lab to Gladstone
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
Subscribe To Our Newsletter & Stay Updated
